ZA986593B - A method for the treatment of staphylococcal disease - Google Patents
A method for the treatment of staphylococcal diseaseInfo
- Publication number
- ZA986593B ZA986593B ZA986593A ZA986593A ZA986593B ZA 986593 B ZA986593 B ZA 986593B ZA 986593 A ZA986593 A ZA 986593A ZA 986593 A ZA986593 A ZA 986593A ZA 986593 B ZA986593 B ZA 986593B
- Authority
- ZA
- South Africa
- Prior art keywords
- lysostaphin
- staphylococcal
- treatment
- staphylococcal disease
- penicillins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24075—Lysostaphin (3.4.24.75)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5347097P | 1997-07-23 | 1997-07-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA986593B true ZA986593B (en) | 1999-02-04 |
Family
ID=21984478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA986593A ZA986593B (en) | 1997-07-23 | 1998-07-23 | A method for the treatment of staphylococcal disease |
Country Status (20)
Country | Link |
---|---|
US (1) | US20020006406A1 (zh) |
EP (1) | EP1001804B1 (zh) |
JP (1) | JP2001510805A (zh) |
KR (1) | KR20010022237A (zh) |
CN (1) | CN1269727A (zh) |
AT (1) | ATE316794T1 (zh) |
AU (1) | AU754806B2 (zh) |
BR (1) | BR9811535A (zh) |
CA (1) | CA2297083C (zh) |
DE (1) | DE69833377T2 (zh) |
HU (1) | HUP0002662A3 (zh) |
IL (1) | IL134056A0 (zh) |
NO (1) | NO320884B1 (zh) |
NZ (1) | NZ502359A (zh) |
PL (1) | PL338178A1 (zh) |
RU (1) | RU2234940C2 (zh) |
SK (1) | SK732000A3 (zh) |
TW (1) | TWI235656B (zh) |
WO (1) | WO1999004809A1 (zh) |
ZA (1) | ZA986593B (zh) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7232576B2 (en) | 1997-10-31 | 2007-06-19 | New Horizons Diagnostics Corp | Throat lozenge for the treatment of Streptococcus Group A |
US6399098B1 (en) | 1997-10-31 | 2002-06-04 | New Horizons Diagnostics Corp | Composition for treating dental caries caused by streptococcus mutans |
US6406692B1 (en) | 1997-10-31 | 2002-06-18 | New Horizons Diagnostics Corp | Composition for treatment of an ocular bacterial infection |
US6423299B1 (en) | 1997-10-31 | 2002-07-23 | Vincent Fischetti | Composition for treatment of a bacterial infection of an upper respiratory tract |
US6399097B1 (en) | 1997-10-31 | 2002-06-04 | New Horizons Diagnostics Corporation | Composition for treatment of a bacterial infection of the digestive tract |
US6428784B1 (en) | 1997-10-31 | 2002-08-06 | New Horizons Diagnostics Corp | Vaginal suppository for treating group B Streptococcus infection |
US6277399B1 (en) | 1997-10-31 | 2001-08-21 | New Horizon Diagnostics Corporation | Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
US6432444B1 (en) | 1997-10-31 | 2002-08-13 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymes for treating dermatological infections |
US6056954A (en) * | 1997-10-31 | 2000-05-02 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses |
US6569830B1 (en) * | 1999-03-05 | 2003-05-27 | Ambi, Inc. | Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains |
US20020127215A1 (en) * | 1999-09-14 | 2002-09-12 | Lawrence Loomis | Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
US20020187136A1 (en) * | 2000-04-28 | 2002-12-12 | Lawrence Loomis | Use of bacterial phage associated lysing enzymes for treating various illnesses |
US6395504B1 (en) | 2000-09-01 | 2002-05-28 | New Horizons Diagnostics Corp. | Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants |
AU2003237789A1 (en) * | 2002-03-26 | 2003-10-13 | Biosynexus, Incorporated | Enzyme disruption of bacterial biofilms |
AU2003298770A1 (en) * | 2002-12-02 | 2004-06-23 | Biosynexus Inc | Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
CN1744905A (zh) * | 2002-12-10 | 2006-03-08 | 百敖新纳斯有限公司 | 局部抗感染制剂 |
US20100221237A1 (en) * | 2003-03-26 | 2010-09-02 | Biosynexus Incorporated | Enzyme disruption of bacterial biofilms |
KR20070104590A (ko) * | 2005-01-10 | 2007-10-26 | 나비 바이오파마슈티컬즈 | 스타필로코쿠스 아우레우스 감염을 치료하는 방법 |
US8273339B2 (en) * | 2005-04-12 | 2012-09-25 | Nektar Therapeutics | Polymer-based compositions and conjugates of antimicrobial agents |
ES2346808T3 (es) | 2006-03-31 | 2010-10-20 | The University Court Of The University Of St. Andrews | Composiciones antimicrobianas que comprenden un peptido cationico y una endopeptidasa de glicilglicina. |
CN103436507B (zh) | 2006-05-05 | 2016-04-20 | 冈戈根股份有限公司 | 噬菌体衍生的抗微生物活性剂 |
WO2009114520A2 (en) * | 2008-03-10 | 2009-09-17 | Pharmain Corporation | Compositions for treatment with metallopeptidases, methods of making and using the same |
WO2009150171A1 (en) * | 2008-06-10 | 2009-12-17 | Profos Ag | Method of treatment of inflammatory diseases |
CN113717964A (zh) | 2013-08-06 | 2021-11-30 | 达特茅斯学院理事会 | 非糖基化溶葡球菌素变体蛋白 |
RU2572341C2 (ru) * | 2013-09-20 | 2016-01-10 | Федеральное государственное бюджетное учреждение Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе Российской академии медицинских наук (ФГБУ "НИИНА" РАМН) | АНТИБИОТИК ИНА 5812, ШТАММ-ПРОДУЦЕНТ Streptomyces roseoflavus ИНА-Ас-5812 И СПОСОБ ПОЛУЧЕНИЯ АНТИБИОТИКА |
CN109819650A (zh) * | 2017-09-25 | 2019-05-28 | 春布里泽·格奥尔基·格奥尔基耶维奇 | 具有抗病毒和抗细菌活性的热稳定组合物及其用途 |
US11565024B2 (en) | 2017-11-16 | 2023-01-31 | Georgia Tech Research Corporation | Lysostaphin containing synthetic hydrogel carriers for bone repair |
CN110917339B (zh) * | 2019-12-27 | 2023-07-07 | 遵义医学院附属医院 | 一种溶葡萄球菌酶凝胶剂及其在mrsa感染创面中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5858962A (en) * | 1987-05-11 | 1999-01-12 | Ambi Inc. | Composition for treating mastitis and other staphylococcal infections |
AU623864B2 (en) * | 1988-08-29 | 1992-05-28 | Applied Microbiology, Inc | Method of treating mastitis and other staphylococcal infections |
-
1998
- 1998-07-21 BR BR9811535-9A patent/BR9811535A/pt not_active IP Right Cessation
- 1998-07-21 DE DE69833377T patent/DE69833377T2/de not_active Expired - Lifetime
- 1998-07-21 AU AU85095/98A patent/AU754806B2/en not_active Ceased
- 1998-07-21 AT AT98935954T patent/ATE316794T1/de not_active IP Right Cessation
- 1998-07-21 RU RU2000104516/15A patent/RU2234940C2/ru not_active IP Right Cessation
- 1998-07-21 WO PCT/US1998/015257 patent/WO1999004809A1/en not_active Application Discontinuation
- 1998-07-21 SK SK73-2000A patent/SK732000A3/sk unknown
- 1998-07-21 HU HU0002662A patent/HUP0002662A3/hu unknown
- 1998-07-21 PL PL98338178A patent/PL338178A1/xx not_active Application Discontinuation
- 1998-07-21 CA CA002297083A patent/CA2297083C/en not_active Expired - Fee Related
- 1998-07-21 IL IL13405698A patent/IL134056A0/xx unknown
- 1998-07-21 NZ NZ502359A patent/NZ502359A/en unknown
- 1998-07-21 US US09/120,030 patent/US20020006406A1/en not_active Abandoned
- 1998-07-21 EP EP98935954A patent/EP1001804B1/en not_active Expired - Lifetime
- 1998-07-21 JP JP2000503861A patent/JP2001510805A/ja active Pending
- 1998-07-21 CN CN98808669A patent/CN1269727A/zh active Pending
- 1998-07-21 KR KR1020007000810A patent/KR20010022237A/ko not_active Application Discontinuation
- 1998-07-23 ZA ZA986593A patent/ZA986593B/xx unknown
- 1998-08-29 TW TW087112047A patent/TWI235656B/zh not_active IP Right Cessation
-
2000
- 2000-01-21 NO NO20000314A patent/NO320884B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
BR9811535A (pt) | 2000-08-29 |
SK732000A3 (en) | 2001-03-12 |
DE69833377D1 (de) | 2006-04-13 |
PL338178A1 (en) | 2000-10-09 |
DE69833377T2 (de) | 2006-11-16 |
US20020006406A1 (en) | 2002-01-17 |
EP1001804B1 (en) | 2006-02-01 |
CN1269727A (zh) | 2000-10-11 |
NO20000314L (no) | 2000-03-16 |
TWI235656B (en) | 2005-07-11 |
WO1999004809A1 (en) | 1999-02-04 |
RU2234940C2 (ru) | 2004-08-27 |
HUP0002662A2 (hu) | 2000-12-28 |
ATE316794T1 (de) | 2006-02-15 |
NZ502359A (en) | 2005-02-25 |
KR20010022237A (ko) | 2001-03-15 |
NO320884B1 (no) | 2006-02-06 |
HUP0002662A3 (en) | 2003-08-28 |
IL134056A0 (en) | 2001-04-30 |
NO20000314D0 (no) | 2000-01-21 |
AU754806B2 (en) | 2002-11-28 |
HU0002662D0 (en) | 2000-08-28 |
EP1001804A1 (en) | 2000-05-24 |
CA2297083A1 (en) | 1999-02-04 |
AU8509598A (en) | 1999-02-16 |
CA2297083C (en) | 2007-10-30 |
JP2001510805A (ja) | 2001-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA986593B (en) | A method for the treatment of staphylococcal disease | |
WO2002003911A3 (en) | Prevention and treatment of alzheimer's disease | |
CA2370030A1 (en) | Sodium channel blocker compositions and the use thereof | |
ES2191066T3 (es) | Preparacion enantioselectiva de sulfoxidos farmaceuticamente activos por biooxidacion. | |
PT806941E (pt) | Composicoes anti-bacterianas liposomicas de rigidez baixa | |
AU2119200A (en) | Medicament | |
WO1999063978A3 (en) | Methods of treating microbial infection and therapeutic formulations therefor | |
AU2005099A (en) | Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections | |
WO2000012049A3 (en) | A method for the treatment of staphylococcal disease | |
WO2000000214A3 (en) | Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms | |
WO2002005642A3 (en) | Synergistic biocidal compositions | |
WO1997018790A3 (en) | Therapeutic and diagnostic agents for the treatment of microbial infections | |
WO2001091796A8 (en) | Methods, compounds and compositions for treating gout | |
AU6633596A (en) | Improved therapeutic agents | |
BG103512A (en) | Substituted pyramidine compounds and their application | |
BG103958A (en) | Pharmaceutical compositions of thioxanide and nitazoxanide | |
AUPP325398A0 (en) | Improved method for eradicating h. pylori | |
HUP0103660A2 (hu) | Mikróbaeredetű hialuronsavbontó enzimet tartalmazó gyógyászati készítmény | |
EP1671644A3 (en) | Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections | |
WO2003103699A8 (en) | USE OF RAMOPLANIN TO TREAT DISORDERS ASSOCIATED WITH THE TAKING OF ANTIBIOTICS | |
WO2004041244A3 (en) | Oral extended release tablets and methods of making and using the same | |
MX9604692A (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
WO1995005364A3 (en) | Inhibitors of biogenic amine transporters | |
GEP20033144B (en) | Hygromycin A Derivatives as Antibacterial Agents | |
AU6003900A (en) | New use of a macrolide compound |